Myriad Genetics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MYGN and other ETFs, options, and stocks.

About MYGN

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. It operates through the Diagnostics and Other segments.

CEO

Paul J. Diaz

CEOPaul J. Diaz

Employees

2,700

Employees2,700

Headquarters

Salt Lake City, Utah

HeadquartersSalt Lake City, Utah

Founded

1991

Founded1991

Employees

2,700

Employees2,700

MYGN Key Statistics

Market cap

1.73B

Market cap1.73B

Price-Earnings ratio

-6.08

Price-Earnings ratio-6.08

Dividend yield

—

Dividend yield—

Average volume

681.89K

Average volume681.89K

High today

$19.74

High today$19.74

Low today

$19.05

Low today$19.05

Open price

$19.67

Open price$19.67

Volume

486.78K

Volume486.78K

52 Week high

$24.21

52 Week high$24.21

52 Week low

$13.82

52 Week low$13.82

MYGN News

Simply Wall St 11h

Myriad Genetics shareholders are up 8.3% this past week, but still in the red over the last five years - Simply Wall St

For many, the main point of investing is to generate higher returns than the overall market. But every investor is virtually certain to have both over-performin...

Yahoo Finance 2d

Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024 - Yahoo Finance

Myriad Genetics, Inc. Management will also participate in four upcoming investor healthcare conferences SALT LAKE CITY, April 30, 2024 (GLOBE NEWSWIRE) -- Myr...

Analyst ratings

46%

of 13 ratings

Buy

30.8%

Hold

46.2%

Sell

23.1%